World & Health

Rio 2026: Global Lung Health Leaders Prepare to Set the Next TB Priorities

The Union World Conference on Lung Health opens in Rio de Janeiro on 17 November, with WHO sessions on TB strategy, new research and the post-2030 response.

Global health experts and lung health advocates gather at The Union World Conference on Lung Health 2026 in Rio de Janeiro, Brazil, to advance tuberculosis prevention, diagnosis, treatment and equitable access to lung health services.
Global health experts and lung health advocates gather at The Union World Conference on Lung Health 2026 in Rio de Janeiro, Brazil, to advance tuberculosis prevention, diagnosis, treatment and equitable access to lung health services.

The decision brief

What is changing?

The Union World Conference on Lung Health convenes in Rio from 17–20 November 2026, with WHO sessions on TB strategy, the Global TB Report and the post-2030 response.

What is coming next?

WHO will present the 2026 Global TB Report findings, convene the Global #EndTB Symposium and gather technical input on a post-2030 TB strategy.

What does it mean?

The agenda is relevant to African TB programmes facing diagnostic gaps, drug resistance, financing pressures and the need to integrate lung health into primary care.

What solutions are available?

WHO-recommended rapid diagnostics, prevention and effective treatment are established priorities; investigational regimens and long-acting approaches require further evidence and review.

Who is offering them?

WHO, The Union, national TB programmes, research consortia, health providers, civil society and development partners.

Rio de Janeiro, Brazil — Global tuberculosis and lung health leaders will meet in Rio de Janeiro from 17 to 20 November for The Union World Conference on Lung Health 2026, a major scientific gathering taking place as countries confront persistent gaps in TB diagnosis, treatment access and financing.

The meeting at the Windsor Convention & Expo Center will bring together researchers, clinicians, public health practitioners, advocates, policymakers and affected communities. The programme is expected to focus on translating evidence into stronger prevention, diagnosis, treatment and integrated lung health services.

WHO puts the future of the TB response on the agenda

The World Health Organization (WHO) will convene sessions on strategic priorities, present findings from the Global Tuberculosis Report 2026 and contribute to discussions on the next phase of the global TB response. A WHO End TB Strategy Summit is scheduled for 15 November, ahead of the main conference. On 17 November, the WHO Global #EndTB Symposium will present findings from the 2026 report; a separate expert consultation on 18 November will gather technical input for a post-2030 global TB strategy.

New treatment research and community perspectives

The UNITE4TB consortium has announced that first results from its PARADIGM4TB Phase 2 platform trial will be presented during the conference, including findings on regimens containing ganfeborole and BTZ-043. These are research findings, not evidence of routine-care availability. Other discussions will consider long-acting injectable TB treatment and prevention; these approaches remain under research and development and will require further evidence, regulatory review and access planning.

Why the meeting matters beyond Rio

WHO estimates that 10.6 million people developed TB in 2025 and about 1.13 million died. Although domestic TB funding increased, international financing fell and millions of people with TB were still not diagnosed or reported. For African health systems, the discussions are relevant to rapid molecular testing, drug-resistant TB services, community-led care, integrated respiratory health and sustainable domestic financing.

What this means

What is changing? The global TB community is reviewing evidence and priorities as it approaches the next phase of the End TB effort.

What comes next? WHO consultations and conference discussions will inform future strategy, research and implementation priorities.

What does it mean? Countries will need stronger domestic financing, earlier diagnosis and accessible treatment if progress is to accelerate.

What solutions are available? WHO-recommended rapid diagnostics, effective treatment, prevention, community engagement and integrated primary care are established priorities; new regimens and long-acting approaches remain under evaluation.

Who is offering them? National TB programmes, WHO, The Union, research consortia, civil society and development partners.

Sources

The Union World Conference on Lung Health 2026; WHO programme at the conference; UNITE4TB conference update; WHO Global TB Report 2026 news release.

Discussion

Leave a Reply

Your email address will not be published. Required fields are marked *